Mulmit

Humacyte, Inc.Humacyte, Inc.

HUMA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-312,038,000-108,137,000-40,833,184-0.26
2024-12-310-114,398,000-148,701,234-1.26

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-20Jones Keith Anthony10,000
2026-08-17Jones Keith Anthony30,000
2026-06-11Windham-Bannister Susan Richards80,000
2026-06-11Constantino Michael T.80,000
2026-06-11Wallace Max N.80,000
2026-06-11Niklason Laura EPresident, CEO and Director80,000
2026-06-11Sebelius Kathleen80,000
2026-06-11Jones Keith Anthony80,000
2026-06-11Green Charles Bruce80,000
2026-06-11Seimetz Diane80,000
2026-06-11Bamforth John Philip80,000
2026-06-11Brown Emery N.80,000

8-K events

FiledItems
2026-08-12Results of operations · Financial statements and exhibits
2026-07-31Delisting or listing-standard notice
2026-06-11Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-06-10Other events · Financial statements and exhibits
2026-06-09Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-06-05Other events
2026-05-08Delisting or listing-standard notice
2026-04-24Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.